Passage BIO, Inc. (PASG)
Latest PASG Insider Trades
- Lynx1 Capital Management LP - 10% OwnerOpen-market purchase$206K
William Chou - OfficerOpen-market sale
About Passage BIO, Inc. (PASG)
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
- PHILADELPHIA, PA
- 24
- 2020
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 50,055 | $206K |
PASG Insider Transactions (Form 4)
4425 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP - 10% Owner | Open-market purchase | Common stock, $0.0001 par value per share ("Common Stock") |
Recent PASG Form 8-K Filings
5PASG Insider Trading - FAQ
What is the latest insider trade for PASG?
Passage BIO, Inc. (PASG) had 1 insider filing in the last 90 days, with the most recent on 2026-06-29. The full record for PASG runs to 25 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying PASG stock?
1 insider purchase of PASG was filed in the last 90 days, totaling $206K.
How many insiders are selling PASG stock?
No insider sales of PASG were filed in the last 90 days. 17 sales are on record for this company.
Where can I see PASG SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks PASG Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow PASG insider buys?
Create a free InsiderAlpha account and press Watch on this page to add PASG to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Lynx1 Capital Management LP view on EDGAR
- - Dolan Sondhi view on EDGAR
- - Derrell Porter view on EDGAR
- - Thomas Richard Kassberg view on EDGAR
- - Sandip Kapadia view on EDGAR
- - Maxine Gowen view on EDGAR
- - Athena Countouriotis view on EDGAR
- - Kathleen Borthwick view on EDGAR
- - William Chou view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where PASG's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track PASG insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
